Molecular aspects of development and regulation of endometriosis

Reproductive Biology and Endocrinology

Volumn 12, Issue 1, 2014, Pages

  Aznaurova, Yana B ^a,c,e   Zhumataev, Marat B ^a,c,e   Roberts, Tiffany K ^b   Aliper, Alexander M ^c,e,f   Zhavoronkov, Alex A ^a,c,d  

^a I M SECHENOV FIRST MOSCOW STATE MEDICAL UNIVERSITY   (Russian Federation)

^b EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^c First Open Institute for Regenerative Medicine for Young Scientists   (Russian Federation)

^d Biogerontology Research Foundation   (United Kingdom)

^e Federal Research Center of Pediatric Hematology Oncology and Immunology   (Russian Federation)

^f MOSCOW INSTITUTE OF PHYSICS AND TECHNOLOGY   (Russian Federation)

Author keywords

Bioinformatics analysis; Biomarkers; Endometriosis; Reproductive age; Signaling pathways; Therapeutic targets

Indexed keywords

2,3,7,8 TETRACHLORODIBENZO PARA DIOXIN; ANDROGEN; ANGIOPOIETIN; EPIDERMAL GROWTH FACTOR; ESTRADIOL; GONADORELIN AGONIST; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 6; JANUS KINASE; LEVONORGESTREL; LIPOCORTIN 5; MICRORNA; ORAL CONTRACEPTIVE AGENT; PLATELET DERIVED GROWTH FACTOR; PROLACTIN; PROSTAGLANDIN SYNTHASE INHIBITOR; SCATTER FACTOR; SMAD PROTEIN; SOMATOMEDIN; STAT PROTEIN; TESTOSTERONE DERIVATIVE; TRANSCRIPTOME; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; VASCULOTROPIN; VASCULOTROPIN A; BIOLOGICAL MARKER;

AGE; ANGIOGENESIS; APOPTOSIS; AUTOIMMUNITY; BIOINFORMATICS; CELL ADHESION; CELL INVASION; CELL PROLIFERATION; DIAGNOSTIC PROCEDURE; EMBRYO DEVELOPMENT; ENDOMETRIOSIS; ENDOMETRIUM CELL; EPIGENETICS; GENETIC ASSOCIATION; GENOMICS; HORMONAL THERAPY; HORMONE RECEPTOR INTERACTION; HUMAN; IMMUNE RESPONSE; LIFESTYLE; LYMPH VESSEL METASTASIS; MENSTRUATION; METAPLASIA; MOLECULAR MECHANICS; PATIENT MONITORING; PREGNANCY RATE; PREVALENCE; PROTEOMICS; REVIEW; RISK FACTOR; SCREENING TEST; SHIFT WORKER; SIGNAL TRANSDUCTION; SMOOTH MUSCLE FIBER; ANIMAL; BIOLOGY; DISEASE COURSE; FEMALE; INFERTILITY, FEMALE; METABOLISM; NEOVASCULARIZATION (PATHOLOGY); PATHOPHYSIOLOGY; PROCEDURES;

ANIMALS; APOPTOSIS; BIOLOGICAL MARKERS; CELL PROLIFERATION; COMPUTATIONAL BIOLOGY; DISEASE PROGRESSION; ENDOMETRIOSIS; FEMALE; HUMANS; INFERTILITY, FEMALE; NEOVASCULARIZATION, PATHOLOGIC; SIGNAL TRANSDUCTION;

EID: 84902070433     PISSN: None     EISSN: 14777827     Source Type: Journal    
DOI: 10.1186/1477-7827-12-50     Document Type: Review

References (245)

1. Meuleman C, Tomassetti C, Gaspar Da Vitoria Magro M, Van Cleynenbreugel B, D'Hoore A, D'Hooghe T. Laparoscopic treatment of endometriosis. Minerva Ginecol 2013, 65:125-142.
2. Chapron C, Bourret A, Chopin N, Dousset B, Leconte M, Amsellem-Ouazana D, de Ziegler D, Borghese B. Surgery for bladder endometriosis: long-term results and concomitant management of associated posterior deep lesions. Hum Reprod 2010, 25:884-889. 10.1093/humrep/deq017, 20129993.
3. Revised american society for reproductive medicine classification of endometriosis: 1996. Fertil Steril 1997, 67:817-821. http://www.ncbi.nlm.nih.gov/pubmed/9130884, 10.1016/S0015-0282(97)81391-X, 9130884.
4. Giudice LC, Kao LC. Endometriosis. Lancet 2004, 364:1789-1799. 10.1016/S0140-6736(04)17403-5, 15541453.
5. Abbas S, Ihle P, Koster I, Schubert I. Prevalence and incidence of diagnosed endometriosis and risk of endometriosis in patients with endometriosis-related symptoms: findings from a statutory health insurance-based cohort in Germany. Eur J Obstet Gynecol Reprod Biol 2012, 160:79-83. 10.1016/j.ejogrb.2011.09.041, 22048012.
6. Janssen EB, Rijkers AC, Hoppenbrouwers K, Meuleman C, D'Hooghe TM. Prevalence of endometriosis diagnosed by laparoscopy in adolescents with dysmenorrhea or chronic pelvic pain: a systematic review. Hum Reprod Update 2013, 19(5):570-582. 10.1093/humupd/dmt016, 23727940.
7. Ballard KD, Seaman HE, de Vries CS, Wright JT. Can symptomatology help in the diagnosis of endometriosis? Findings from a national case-control study-Part 1. BJOG 2008, 115:1382-1391. 10.1111/j.1471-0528.2008.01878.x, 18715240.
8. Haas D, Chvatal R, Reichert B, Renner S, Shebl O, Binder H, Wurm P, Oppelt P. Endometriosis: a premenopausal disease? Age pattern in 42,079 patients with endometriosis. Arch Gynecol Obstet 2012, 286:667-670. 10.1007/s00404-012-2361-z, 22562384.
9. McArthur JW, Ulfelder H. The effect of pregnancy upon endometriosis. Obstet Gynecol Surv 1965, 20:709-733. 10.1097/00006254-196510000-00001, 5318470.
10. Ueda Y, Enomoto T, Miyatake T, Fujita M, Yamamoto R, Kanagawa T, Shimizu H, Kimura T. A retrospective analysis of ovarian endometriosis during pregnancy. Fertil Steril 2010, 94:78-84. 10.1016/j.fertnstert.2009.02.092, 19356751.
11. Yuan P, Huang Y, Cheng B, Zhang J, Xin X. Induction of a local pseudo-pregnancy for the treatment of endometriosis. Med Hypotheses 2010, 74:56-58. 10.1016/j.mehy.2009.08.001, 19699590.
12. Davis L, Kennedy SS, Moore J, Prentice A. Modern combined oral contraceptives for pain associated with endometriosis. Cochrane Database Syst Rev 2007, CD001019.
13. Kistner RW. The use of newer progestins in the treatment of endometriosis. Am J Obstet Gynecol 1958, 75:264-278.
14. Marino JL, Holt VL, Chen C, Davis S. Shift work, hCLOCK T3111C polymorphism, and endometriosis risk. Epidemiology 2008, 19:477-484. 10.1097/EDE.0b013e31816b7378, 2931326, 18379422.
15. Bao AM, Liu RY, van Someren EJ, Hofman MA, Cao YX, Zhou JN. Diurnal rhythm of free estradiol during the menstrual cycle. Eur J Endocrinol 2003, 148:227-232. 10.1530/eje.0.1480227, 12590642.
16. Carandente F, Angeli A, Crosignani P, Dammacco F, De Cecco L, Ferrario VF, Halberg F, Marrama P, Martini L, Massobrio M. Circatrigintan rectal temperature and endocrine rhythms of clinically healthy, menstrually cycling women. Prog Clin Biol Res 1987, 227B:533-548.
17. Chung FF, Yao CC, Wan GH. The associations between menstrual function and life style/working conditions among nurses in Taiwan. J Occup Health 2005, 47:149-156. 10.1539/joh.47.149, 15824480.
18. Kakegawa H, Mitsuo N, Matsumoto H, Satoh T, Akagi M, Tasaka K. Hyaluronidase-inhibitory and anti-allergic activities of the photo-irradiated products of tranilast. Chem Pharm Bull (Tokyo) 1985, 33:3738-3744. 10.1248/cpb.33.3738, 2418990.
19. DeVito MJ, Birnbaum LS, Farland WH, Gasiewicz TA. Comparisons of estimated human body burdens of dioxinlike chemicals and TCDD body burdens in experimentally exposed animals. Environ Health Perspect 1995, 103:820-831. 10.1289/ehp.95103820, 1519223, 7498094.
20. Safe SH. Polychlorinated biphenyls (PCBs): environmental impact, biochemical and toxic responses, and implications for risk assessment. Crit Rev Toxicol 1994, 24:87-149. 10.3109/10408449409049308, 8037844.
21. Whitlock JP. The aromatic hydrocarbon receptor, dioxin action, and endocrine homeostasis. Trends Endocrinol Metab 1994, 5:183-188. 10.1016/1043-2760(94)90075-2, 18407206.
22. Rysavy NM, Maaetoft-Udsen K, Turner H. Dioxins: diagnostic and prognostic challenges arising from complex mechanisms. J Appl Toxicol 2013, 33:1-8. 10.1002/jat.2759, 3808465, 22610997.
23. Assessment of the health risk of dioxins: re-evaluation of the tolerable daily intake (TDI). Geneva, Switzerland, 25-29 May 1998. Food Addit Contam 2000, 17:223-369. http://www.ncbi.nlm.nih.gov/pubmed/9130884).
24. Lorber M, Patterson D, Huwe J, Kahn H. Evaluation of background exposures of Americans to dioxin-like compounds in the 1990s and the 2000s. Chemosphere 2009, 77:640-651. 10.1016/j.chemosphere.2009.08.016, 19733382.
25. Cummings AM, Metcalf JL, Birnbaum L. Promotion of endometriosis by 2,3,7,8-tetrachlorodibenzo-p-dioxin in rats and mice: time-dose dependence and species comparison. Toxicol Appl Pharmacol 1996, 138:131-139. 10.1006/taap.1996.0106, 8658502.
26. Johnson KL, Cummings AM, Birnbaum LS. Promotion of endometriosis in mice by polychlorinated dibenzo-p-dioxins, dibenzofurans, and biphenyls. Environ Health Perspect 1997, 105:750-755. 10.1289/ehp.97105750, 1470109, 9294722.
27. Cummings AM, Hedge JM, Birnbaum LS. Effect of prenatal exposure to TCDD on the promotion of endometriotic lesion growth by TCDD in adult female rats and mice. Toxicol Sci 1999, 52:45-49. 10.1093/toxsci/52.1.45, 10568697.
28. Rier SE, Martin DC, Bowman RE, Dmowski WP, Becker JL. Endometriosis in rhesus monkeys (Macaca mulatta) following chronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin. Fundam Appl Toxicol 1993, 21:433-441. 10.1006/faat.1993.1119, 8253297.
29. Yang JZ, Agarwal SK, Foster WG. Subchronic exposure to 2,3,7,8-tetrachlorodibenzo-p-dioxin modulates the pathophysiology of endometriosis in the cynomolgus monkey. Toxicol Sci 2000, 56:374-381. 10.1093/toxsci/56.2.374, 10910996.
30. Bruner KL, Matrisian LM, Rodgers WH, Gorstein F, Osteen KG. Suppression of matrix metalloproteinases inhibits establishment of ectopic lesions by human endometrium in nude mice. J Clin Invest 1997, 99:2851-2857. 10.1172/JCI119478, 508135, 9185507.
31. Bruner-Tran KL, Rier SE, Eisenberg E, Osteen KG. The potential role of environmental toxins in the pathophysiology of endometriosis. Gynecol Obstet Invest 1999, 48(Suppl 1):45-56.
32. Heilier JF, Donnez J, Nackers F, Rousseau R, Verougstraete V, Rosenkranz K, Donnez O, Grandjean F, Lison D, Tonglet R. Environmental and host-associated risk factors in endometriosis and deep endometriotic nodules: a matched case-control study. Environ Res 2007, 103:121-129. 10.1016/j.envres.2006.04.004, 16781705.
33. Mayani A, Barel S, Soback S, Almagor M. Dioxin concentrations in women with endometriosis. Hum Reprod 1997, 12:373-375. 10.1093/humrep/12.2.373, 9070728.
34. Eskenazi B, Mocarelli P, Warner M, Samuels S, Vercellini P, Olive D, Needham L, Patterson D, Brambilla P. Seveso Women's Health Study: a study of the effects of 2,3,7,8-tetrachlorodibenzo-p-dioxin on reproductive health. Chemosphere 2000, 40:1247-1253. 10.1016/S0045-6535(99)00376-8, 10739069.
35. Rier SE. The potential role of exposure to environmental toxicants in the pathophysiology of endometriosis. Ann N Y Acad Sci 2002, 955:201-212. discussion 230-202, 396-406, 10.1111/j.1749-6632.2002.tb02781.x, 11949948.
36. Eisenberg VH, Zolti M, Soriano D. Is there an association between autoimmunity and endometriosis?. Autoimmun Rev 2012, 11:806-814. 10.1016/j.autrev.2012.01.005, 22330229.
37. Bulun SE. Endometriosis. N Engl J Med 2009, 360:268-279. 10.1056/NEJMra0804690, 19144942.
38. Matarese G, De Placido G, Nikas Y, Alviggi C. Pathogenesis of endometriosis: natural immunity dysfunction or autoimmune disease?. Trends Mol Med 2003, 9:223-228. 10.1016/S1471-4914(03)00051-0, 12763528.
39. Sundqvist J, Falconer H, Seddighzadeh M, Vodolazkaia A, Fassbender A, Kyama C, Bokor A, Stephansson O, Padyukov L, Gemzell-Danielsson K, D'Hooghe TM. Endometriosis and autoimmune disease: association of susceptibility to moderate/severe endometriosis with CCL21 and HLA-DRB1. Fertil Steril 2011, 95:437-440. 10.1016/j.fertnstert.2010.07.1060, 20797713.
40. Sinaii N, Cleary SD, Ballweg ML, Nieman LK, Stratton P. High rates of autoimmune and endocrine disorders, fibromyalgia, chronic fatigue syndrome and atopic diseases among women with endometriosis: a survey analysis. Hum Reprod 2002, 17:2715-2724. 10.1093/humrep/17.10.2715, 12351553.
41. Jess T, Frisch M, Jorgensen KT, Pedersen BV, Nielsen NM. Increased risk of inflammatory bowel disease in women with endometriosis: a nationwide Danish cohort study. Gut 2012, 61:1279-1283. 10.1136/gutjnl-2011-301095, 22184069.
42. Mathur SP. Autoimmunity in endometriosis: relevance to infertility. Am J Reprod Immunol 2000, 44:89-95. 10.1111/j.8755-8920.2000.440204.x, 10994636.
43. Inagaki J, Kondo A, Lopez LR, Shoenfeld Y, Matsuura E. Pregnancy loss and endometriosis: pathogenic role of anti-laminin-1 autoantibodies. Ann N Y Acad Sci 2005, 1051:174-184. 10.1196/annals.1361.059, 16126957.
44. Inagaki J, Hao L, Nakatsuka M, Yasuda T, Hiramatsu Y, Shoenfeld Y, Matsuura E. A possible mechanism of autoimmune-mediated infertility in women with endometriosis. Am J Reprod Immunol 2011, 66:90-99. 10.1111/j.1600-0897.2010.00956.x, 21223425.
45. Gajbhiye R, Suryawanshi A, Khan S, Meherji P, Warty N, Raut V, Chehna N, Khole V. Multiple endometrial antigens are targeted in autoimmune endometriosis. Reprod Biomed Online 2008, 16:817-824. 10.1016/S1472-6483(10)60147-2, 18549691.
46. Halme J, Hammond MG, Hulka JF, Raj SG, Talbert LM. Retrograde menstruation in healthy women and in patients with endometriosis. Obstet Gynecol 1984, 64:151-154.
47. Figueira PG, Abrao MS, Krikun G, Taylor HS. Stem cells in endometrium and their role in the pathogenesis of endometriosis. Ann N Y Acad Sci 2011, 1221:10-17. 10.1111/j.1749-6632.2011.05969.x, 3076708, 21401624.
48. Kao AP, Wang KH, Chang CC, Lee JN, Long CY, Chen HS, Tsai CF, Hsieh TH, Tsai EM. Comparative study of human eutopic and ectopic endometrial mesenchymal stem cells and the development of an in vivo endometriotic invasion model. Fertil Steril 2011, 95:1308-1315. e1301, 10.1016/j.fertnstert.2010.09.064, 21047634.
49. Gruenwald P. Origin of endometriosis from the mesenchyme of the coelomic walls. Am J Obstet Gynecol 1942, 44:474.
50. Mok-Lin EY, Wolfberg A, Hollinquist H, Laufer MR. Endometriosis in a patient with Mayer-Rokitansky-Kuster-Hauser syndrome and complete uterine agenesis: evidence to support the theory of coelomic metaplasia. J Pediatr Adolesc Gynecol 2010, 23:e35-e37. 10.1016/j.jpag.2009.02.010, 19589710.
51. Kerner H, Gaton E, Czernobilsky B. Unusual ovarian, tubal and pelvic mesothelial inclusions in patients with endometriosis. Histopathology 1981, 5:277-283. 10.1111/j.1365-2559.1981.tb01786.x, 6263781.
52. Schrodt GR, Alcorn MO, Ibanez J. Endometriosis of the male urinary system: a case report. J Urol 1980, 124:722-723.
53. Drosdzol A, Skrzypulec V. Endometriosis in pediatric and adolescent gynecology. Ginekol Pol 2008, 79:133-136.
54. Hobbs J, Bortnick A. Endometriosis of the lung: an experimental and clinical study. Am J Obstet Gynecol 1940, 40:843.
55. Matsuura K, Ohtake H, Katabuchi H, Okamura H. Coelomic metaplasia theory of endometriosis: evidence from in vivo studies and an in vitro experimental model. Gynecol Obstet Invest 1999, 47(Suppl 1):18-20. discussion 20-12.
56. Sampson JA. Metastatic or embolic endometriosis, due to the menstrual dissemination of endometrial tissue into the venous circulation. Am J Pathol 1927, 3:93-110. 143, 1931779, 19969738.
57. Karak P, Dimick R, Hamrick KM, Schwartzberg M, Saddekni S. Immediate transcatheter embolization of Swan-Ganz catheter-induced pulmonary artery pseudoaneurysm. Chest 1997, 111:1450-1452. 10.1378/chest.111.5.1450, 9149612.
58. Merlo M, Brunelli F, Annecchino FP, Crupi G, Terzi A, Ziolkowska L. Arterial switch operation: myocardial ischemia reversed by internal mammary artery graft. Ann Thorac Surg 1996, 62:586-588. 10.1016/0003-4975(96)00412-2, 8694637.
59. Sasson IE, Taylor HS. Stem cells and the pathogenesis of endometriosis. Ann N Y Acad Sci 2008, 1127:106-115. 10.1196/annals.1434.014, 3107843, 18443337.
60. Macer ML, Taylor HS. Endometriosis and infertility: a review of the pathogenesis and treatment of endometriosis-associated infertility. Obstet Gynecol Clin North Am 2012, 39:535-549. 10.1016/j.ogc.2012.10.002, 3538128, 23182559.
61. Adachi M, Nasu K, Tsuno A, Yuge A, Kawano Y, Narahara H. Attachment to extracellular matrices is enhanced in human endometriotic stromal cells: a possible mechanism underlying the pathogenesis of endometriosis. Eur J Obstet Gynecol Reprod Biol 2011, 155:85-88. 10.1016/j.ejogrb.2010.10.026, 21112686.
62. Khare VK, Martin DC, Eltorky M. A comparative study of ovarian and pelvic wall-infiltrating endometriosis. J Am Assoc Gynecol Laparosc 1996, 3:235-239. 10.1016/S1074-3804(96)80006-5, 9050632.
63. Anaf V, Simon P, Fayt I, Noel J. Smooth muscles are frequent components of endometriotic lesions. Hum Reprod 2000, 15:767-771. 10.1093/humrep/15.4.767, 10739817.
64. Fukunaga M. Smooth muscle metaplasia in ovarian endometriosis. Histopathology 2000, 36:348-352. 10.1046/j.1365-2559.2000.00845.x, 10759949.
65. van Kaam KJ, Schouten JP, Nap AW, Dunselman GA, Groothuis PG. Fibromuscular differentiation in deeply infiltrating endometriosis is a reaction of resident fibroblasts to the presence of ectopic endometrium. Hum Reprod 2008, 23:2692-2700. 10.1093/humrep/den153, 18716038.
66. Mechsner S, Bartley J, Loddenkemper C, Salomon DS, Starzinski-Powitz A, Ebert AD. Oxytocin receptor expression in smooth muscle cells of peritoneal endometriotic lesions and ovarian endometriotic cysts. Fertil Steril 2005, 83(Suppl 1):1220-1231.
67. Odagiri K, Konno R, Fujiwara H, Netsu S, Yang C, Suzuki M. Smooth muscle metaplasia and innervation in interstitium of endometriotic lesions related to pain. Fertil Steril 2009, 92:1525-1531. 10.1016/j.fertnstert.2008.08.101, 18930216.
68. de Arellano ML B, Gericke J, Reichelt U, Okuducu AF, Ebert AD, Chiantera V, Schneider A, Mechsner S. Immunohistochemical characterization of endometriosis-associated smooth muscle cells in human peritoneal endometriotic lesions. Hum Reprod 2011, 26:2721-2730. 10.1093/humrep/der253, 21831994.
69. van Furth R, Cohn ZA. The origin and kinetics of mononuclear phagocytes. J Exp Med 1968, 128:415-435. 10.1084/jem.128.3.415, 2138527, 5666958.
70. Murray PJ, Wynn TA. Protective and pathogenic functions of macrophage subsets. Nat Rev Immunol 2011, 11:723-737. 10.1038/nri3073, 3422549, 21997792.
71. Bacci M, Capobianco A, Monno A, Cottone L, Di Puppo F, Camisa B, Mariani M, Brignole C, Ponzoni M, Ferrari S, Panina-Bordignon P, Manfredi A, Rovere-Querini P. Macrophages are alternatively activated in patients with endometriosis and required for growth and vascularization of lesions in a mouse model of disease. Am J Pathol 2009, 175:547-556. 10.2353/ajpath.2009.081011, 2716955, 19574425.
72. Lawson C, Al-Akoum M, Maheux R, Akoum A. Increased expression of interleukin-1 receptor type 1 in active endometriotic lesions. Reproduction 2007, 133:265-274. 10.1530/rep.1.01121, 17244752.
73. Lousse JC, Van Langendonckt A, Gonzalez-Ramos R, Defrere S, Renkin E, Donnez J. Increased activation of nuclear factor-kappa B (NF-kappaB) in isolated peritoneal macrophages of patients with endometriosis. Fertil Steril 2008, 90:217-220. 10.1016/j.fertnstert.2007.06.015, 17889859.
74. Zhang C, Maeda N, Izumiya C, Yamamoto Y, Kusume T, Oguri H, Yamashita C, Nishimori Y, Hayashi K, Luo J, Fukaya T. Killer immunoglobulin-like receptor and human leukocyte antigen expression as immunodiagnostic parameters for pelvic endometriosis. Am J Reprod Immunol 2006, 55:106-114. 10.1111/j.1600-0897.2005.00332.x, 16433829.
75. Lebovic DI, Mueller MD, Taylor RN. Immunobiology of endometriosis. Fertil Steril 2001, 75:1-10. 10.1016/S0015-0282(00)01630-7, 11163805.
76. Novembri R, Carrarelli P, Toti P, Rocha AL, Borges LE, Reis FM, Piomboni P, Florio P, Petraglia F. Urocortin 2 and urocortin 3 in endometriosis: evidence for a possible role in inflammatory response. Mol Hum Reprod 2011, 17:587-593. 10.1093/molehr/gar020, 21454316.
77. Jiang QY, Wu RJ. Growth mechanisms of endometriotic cells in implanted places: a review. Gynecol Endocrinol 2012, 28:562-567. 10.3109/09513590.2011.650662, 22296665.
78. Pellegrini C, Gori I, Achtari C, Hornung D, Chardonnens E, Wunder D, Fiche M, Canny GO. The expression of estrogen receptors as well as GREB1, c-MYC, and cyclin D1, estrogen-regulated genes implicated in proliferation, is increased in peritoneal endometriosis. Fertil Steril 2012, 98:1200-1208. 10.1016/j.fertnstert.2012.06.056, 22884659.
79. Chegini N, Rossi MJ, Masterson BJ. Platelet-derived growth factor (PDGF), epidermal growth factor (EGF), and EGF and PDGF beta-receptors in human endometrial tissue: localization and in vitro action. Endocrinology 1992, 130:2373-2385.
80. Klemmt PA, Carver JG, Koninckx P, McVeigh EJ, Mardon HJ. Endometrial cells from women with endometriosis have increased adhesion and proliferative capacity in response to extracellular matrix components: towards a mechanistic model for endometriosis progression. Hum Reprod 2007, 22:3139-3147. 10.1093/humrep/dem262, 17921481.
81. Chung HW, Wen Y, Choi EA, Hao L, Moon HS, Yu HK, Polan ML. Pleiotrophin (PTN) and midkine (MK) mRNA expression in eutopic and ectopic endometrium in advanced stage endometriosis. Mol Hum Reprod 2002, 8:350-355. 10.1093/molehr/8.4.350, 11912283.
82. Olivares C, Bilotas M, Buquet R, Borghi M, Sueldo C, Tesone M, Meresman G. Effects of a selective cyclooxygenase-2 inhibitor on endometrial epithelial cells from patients with endometriosis. Hum Reprod 2008, 23:2701-2708. 10.1093/humrep/den315, 18716040.
83. Bergqvist A, Bruse C, Carlberg M, Carlstrom K. Interleukin 1beta, interleukin-6, and tumor necrosis factor-alpha in endometriotic tissue and in endometrium. Fertil Steril 2001, 75:489-495. 10.1016/S0015-0282(00)01752-0, 11239529.
84. Yoshida S, Harada T, Mitsunari M, Iwabe T, Sakamoto Y, Tsukihara S, Iba Y, Horie S, Terakawa N. Hepatocyte growth factor/Met system promotes endometrial and endometriotic stromal cell invasion via autocrine and paracrine pathways. J Clin Endocrinol Metab 2004, 89:823-832. 10.1210/jc.2003-030874, 14764801.
85. Matarese G, Alviggi C, Sanna V, Howard JK, Lord GM, Carravetta C, Fontana S, Lechler RI, Bloom SR, De Placido G. Increased leptin levels in serum and peritoneal fluid of patients with pelvic endometriosis. J Clin Endocrinol Metab 2000, 85:2483-2487.
86. Vermot J, Fraulob V, Dolle P, Niederreither K. Expression of enzymes synthesizing (aldehyde dehydrogenase 1 and reinaldehyde dehydrogenase 2) and metabolizaing (Cyp26) retinoic acid in the mouse female reproductive system. Endocrinology 2000, 141:3638-3645.
87. Deng L, Shipley GL, Loose-Mitchell DS, Stancel GM, Broaddus R, Pickar JH, Davies PJ. Coordinate regulation of the production and signaling of retinoic acid by estrogen in the human endometrium. J Clin Endocrinol Metab 2003, 88:2157-2163. 10.1210/jc.2002-021844, 12727970.
88. Bock KW, Kohle C. Ah receptor: dioxin-mediated toxic responses as hints to deregulated physiologic functions. Biochem Pharmacol 2006, 72:393-404. 10.1016/j.bcp.2006.01.017, 16545780.
89. Hestermann EV, Brown M. Agonist and chemopreventative ligands induce differential transcriptional cofactor recruitment by aryl hydrocarbon receptor. Mol Cell Biol 2003, 23:7920-7925. 10.1128/MCB.23.21.7920-7925.2003, 207605, 14560034.
90. Safe S, Wormke M, Samudio I. Mechanisms of inhibitory aryl hydrocarbon receptor-estrogen receptor crosstalk in human breast cancer cells. J Mammary Gland Biol Neoplasia 2000, 5:295-306. 10.1023/A:1009550912337, 14973392.
91. Yang X, Liu D, Murray TJ, Mitchell GC, Hesterman EV, Karchner SI, Merson RR, Hahn ME, Sherr DH. The aryl hydrocarbon receptor constitutively represses c-myc transcription in human mammary tumor cells. Oncogene 2005, 24:7869-7881. 10.1038/sj.onc.1208938, 16091746.
92. Iba Y, Harada T, Horie S, Deura I, Iwabe T, Terakawa N. Lipopolysaccharide-promoted proliferation of endometriotic stromal cells via induction of tumor necrosis factor alpha and interleukin-8 expression. Fertil Steril 2004, 82(Suppl 3):1036-1042.
93. Garcia-Velasco JA, Mulayim N, Kayisli UA, Arici A. Elevated soluble Fas ligand levels may suggest a role for apoptosis in women with endometriosis. Fertil Steril 2002, 78:855-859. 10.1016/S0015-0282(02)03320-4, 12372468.
94. Selam B, Kayisli UA, Garcia-Velasco JA, Akbas GE, Arici A. Regulation of fas ligand expression by IL-8 in human endometrium. J Clin Endocrinol Metab 2002, 87:3921-3927. 10.1210/jcem.87.8.8713, 12161534.
95. Watanabe A, Taniguchi F, Izawa M, Suou K, Uegaki T, Takai E, Terakawa N, Harada T. The role of survivin in the resistance of endometriotic stromal cells to drug-induced apoptosis. Hum Reprod 2009, 24:3172-3179. 10.1093/humrep/dep305, 19729377.
96. Nishida M, Nasu K, Ueda T, Fukuda J, Takai N, Miyakawa I. Endometriotic cells are resistant to interferon-gamma-induced cell growth inhibition and apoptosis: a possible mechanism involved in the pathogenesis of endometriosis. Mol Hum Reprod 2005, 11:29-34.
97. Pedraza C, Geberhiwot T, Ingerpuu S, Assefa D, Wondimu Z, Kortesmaa J, Tryggvason K, Virtanen I, Patarroyo M. Monocytic cells synthesize, adhere to, and migrate on laminin-8 (alpha 4 beta 1 gamma 1). J Immunol 2000, 165:5831-5838. 10.4049/jimmunol.165.10.5831, 11067943.
98. Spuijbroek MD, Dunselman GA, Menheere PP, Evers JL. Early endometriosis invades the extracellular matrix. Fertil Steril 1992, 58:929-933.
99. Lessey BA, Castelbaum AJ, Sawin SW, Buck CA, Schinnar R, Bilker W, Strom BL. Aberrant integrin expression in the endometrium of women with endometriosis. J Clin Endocrinol Metab 1994, 79:643-649.
100. Hinck L, Nathke IS, Papkoff J, Nelson WJ. Dynamics of cadherin/catenin complex formation: novel protein interactions and pathways of complex assembly. J Cell Biol 1994, 125:1327-1340. 10.1083/jcb.125.6.1327, 2290923, 8207061.
101. Shaco-Levy R, Sharabi S, Benharroch D, Piura B, Sion-Vardy N. Matrix metalloproteinases 2 and 9, E-cadherin, and beta-catenin expression in endometriosis, low-grade endometrial carcinoma and non-neoplastic eutopic endometrium. Eur J Obstet Gynecol Reprod Biol 2008, 139:226-232. 10.1016/j.ejogrb.2008.01.004, 18295959.
102. Ris HW. The integration of a comprehensive medical program in a juvenile correctional institution. J Am Med Womens Assoc 1975, 30:367-378.
103. Poncelet C, Cornelis F, Tepper M, Sauce E, Magan N, Wolf JP, Ziol M. Expression of E- and N-cadherin and CD44 in endometrium and hydrosalpinges from infertile women. Fertil Steril 2010, 94:2909-2912. 10.1016/j.fertnstert.2010.04.055, 20605145.
104. Gaetje R, Kotzian S, Herrmann G, Baumann R, Starzinski-Powitz A. Nonmalignant epithelial cells, potentially invasive in human endometriosis, lack the tumor suppressor molecule E-cadherin. Am J Pathol 1997, 150:461-467. 1858282, 9033262.
105. Beliard A, Donnez J, Nisolle M, Foidart JM. Localization of laminin, fibronectin, E-cadherin, and integrins in endometrium and endometriosis. Fertil Steril 1997, 67:266-272. 10.1016/S0015-0282(97)81909-7, 9022601.
106. Poncelet C, Leblanc M, Walker-Combrouze F, Soriano D, Feldmann G, Madelenat P, Scoazec JY, Darai E. Expression of cadherins and CD44 isoforms in human endometrium and peritoneal endometriosis. Acta Obstet Gynecol Scand 2002, 81:195-203. 10.1034/j.1600-0412.2002.810302.x, 11966474.
107. Fujimoto J, Ichigo S, Hori M, Tamaya T. Alteration of E-cadherin, alpha- and beta-catenin mRNA expression in human uterine endometrium during the menstrual cycle. Gynecol Endocrinol 1996, 10:187-191. 10.3109/09513599609027987, 8862494.
108. Matsuzaki S, Darcha C. Involvement of the Wnt/beta-catenin signaling pathway in the cellular and molecular mechanisms of fibrosis in endometriosis. PLoS One 2013, 8:e76808. 10.1371/journal.pone.0076808, 3790725, 24124596.
109. Ueda M, Yamashita Y, Takehara M, Terai Y, Kumagai K, Ueki K, Kanda K, Hung YC, Ueki M. Gene expression of adhesion molecules and matrix metalloproteinases in endometriosis. Gynecol Endocrinol 2002, 16:391-402. 10.1080/gye.16.5.391.402, 12587534.
110. Clevers H, Nusse R. Wnt/beta-catenin signaling and disease. Cell 2012, 149:1192-1205. 10.1016/j.cell.2012.05.012, 22682243.
111. Chen GT, Tai CT, Yeh LS, Yang TC, Tsai HD. Identification of the cadherin subtypes present in the human peritoneum and endometriotic lesions: potential role for P-cadherin in the development of endometriosis. Mol Reprod Dev 2002, 62:289-294. 10.1002/mrd.10121, 12112590.
112. Hull ML, Escareno CR, Godsland JM, Doig JR, Johnson CM, Phillips SC, Smith SK, Tavare S, Print CG, Charnock-Jones DS. Endometrial-peritoneal interactions during endometriotic lesion establishment. Am J Pathol 2008, 173:700-715. 10.2353/ajpath.2008.071128, 2527068, 18688027.
113. Koks CA, Groothuis PG, Dunselman GA, de Goeij AF, Evers JL. Adhesion of menstrual endometrium to extracellular matrix: the possible role of integrin alpha(6)beta(1) and laminin interaction. Mol Hum Reprod 2000, 6:170-177. 10.1093/molehr/6.2.170, 10655459.
114. D'Amico F, Skarmoutsou E, Quaderno G, Malaponte G, La Corte C, Scibilia G, D'Agate G, Scollo P, Fraggetta F, Spandidos DA, Mazzarino MC. Expression and localisation of osteopontin and prominin-1 (CD133) in patients with endometriosis. Int J Mol Med 2013, 31:1011-1016. 3658602, 23545719.
115. Chang JH, Au HK, Lee WC, Chi CC, Ling TY, Wang LM, Kao SH, Huang YH, Tzeng CR. Expression of the pluripotent transcription factor OCT4 promotes cell migration in endometriosis. Fertil Steril 2013, 99:1332-1339. e1335, 10.1016/j.fertnstert.2012.11.033, 23290742.
116. Forte A, Schettino MT, Finicelli M, Cipollaro M, Colacurci N, Cobellis L, Galderisi U. Expression pattern of stemness-related genes in human endometrial and endometriotic tissues. Mol Med 2009, 15:392-401. 2727462, 19690622.
117. Braundmeier AG, Nowak RA. Cytokines regulate matrix metalloproteinases in human uterine endometrial fibroblast cells through a mechanism that does not involve increases in extracellular matrix metalloproteinase inducer. Am J Reprod Immunol 2006, 56:201-214. 10.1111/j.1600-0897.2006.00418.x, 16911716.
118. Chung HW, Lee JY, Moon HS, Hur SE, Park MH, Wen Y, Polan ML. Matrix metalloproteinase-2, membranous type 1 matrix metalloproteinase, and tissue inhibitor of metalloproteinase-2 expression in ectopic and eutopic endometrium. Fertil Steril 2002, 78:787-795. 10.1016/S0015-0282(02)03322-8, 12372458.
119. Sharpe-Timms KL, Keisler LW, McIntush EW, Keisler DH. Tissue inhibitor of metalloproteinase-1 concentrations are attenuated in peritoneal fluid and sera of women with endometriosis and restored in sera by gonadotropin-releasing hormone agonist therapy. Fertil Steril 1998, 69:1128-1134. 10.1016/S0015-0282(98)00075-2, 9627304.
120. Hazzard TM, Molskness TA, Chaffin CL, Stouffer RL. Vascular endothelial growth factor (VEGF) and angiopoietin regulation by gonadotrophin and steroids in macaque granulosa cells during the peri-ovulatory interval. Mol Hum Reprod 1999, 5:1115-1121. 10.1093/molehr/5.12.1115, 10587365.
121. Bourlev V, Volkov N, Pavlovitch S, Lets N, Larsson A, Olovsson M. The relationship between microvessel density, proliferative activity and expression of vascular endothelial growth factor-A and its receptors in eutopic endometrium and endometriotic lesions. Reproduction 2006, 132:501-509. 10.1530/rep.1.01110, 16940291.
122. Nap AW, Griffioen AW, Dunselman GA, Bouma-Ter Steege JC, Thijssen VL, Evers JL, Groothuis PG. Antiangiogenesis therapy for endometriosis. J Clin Endocrinol Metab 2004, 89:1089-1095. 10.1210/jc.2003-031406, 15001592.
123. Yancopoulos GD, Davis S, Gale NW, Rudge JS, Wiegand SJ, Holash J. Vascular-specific growth factors and blood vessel formation. Nature 2000, 407:242-248. 10.1038/35025215, 11001067.
124. Seppala M, Koistinen H, Koistinen R, Hautala L, Chiu PC, Yeung WS. Glycodelin in reproductive endocrinology and hormone-related cancer. Eur J Endocrinol 2009, 160:121-133.
125. Julkunen M, Koistinen R, Sjoberg J, Rutanen EM, Wahlstrom T, Seppala M. Secretory endometrium synthesizes placental protein 14. Endocrinology 1986, 118:1782-1786. 10.1210/endo-118-5-1782, 3516653.
126. Telimaa S, Kauppila A, Ronnberg L, Suikkari AM, Seppala M. Elevated serum levels of endometrial secretory protein PP14 in patients with advanced endometriosis. Suppression by treatment with danazol and high-dose medroxyprogesterone acetate. Am J Obstet Gynecol 1989, 161:866-871. 10.1016/0002-9378(89)90738-2, 2801831.
127. Lin YJ, Lai MD, Lei HY, Wing LY. Neutrophils and macrophages promote angiogenesis in the early stage of endometriosis in a mouse model. Endocrinology 2006, 147:1278-1286. 10.1210/en.2005-0790, 16306083.
128. Moskalev AA, Aliper AM, Smit-McBride Z, Buzdin A, Zhavoronkov A. Genetics and epigenetics of aging and longevity. Cell Cycle 2014, 13:1063-1077.
129. Khan KN, Masuzaki H, Fujishita A, Kitajima M, Kohno T, Sekine I, Matsuyama T, Ishimaru T. Regulation of hepatocyte growth factor by basal and stimulated macrophages in women with endometriosis. Hum Reprod 2005, 20:49-60.
130. Sacco K, Portelli M, Pollacco J, Schembri-Wismayer P, Calleja-Agius J. The role of prostaglandin E2 in endometriosis. Gynecol Endocrinol 2012, 28:134-138. 10.3109/09513590.2011.588753, 22003899.
131. Urata Y, Osuga Y, Akiyama I, Nagai M, Izumi G, Takamura M, Hasegawa A, Harada M, Hirata T, Hirota Y, Yoshino O, Koga K, Kozuma S. Interleukin-4 and prostaglandin E2 synergistically up-regulate 3beta-hydroxysteroid dehydrogenase type 2 in endometrioma stromal cells. J Clin Endocrinol Metab 2013, 98:1583-1590. 10.1210/jc.2012-3475, 23450050.
132. Herrmann Lavoie C, Fraser D, Therriault MJ, Akoum A. Interleukin-1 stimulates macrophage migration inhibitory factor secretion in ectopic endometrial cells of women with endometriosis. Am J Reprod Immunol 2007, 58:505-513. 10.1111/j.1600-0897.2007.00471.x, 17997749.
133. Itoh H, Sashihara T, Hosono A, Kaminogawa S, Uchida M. Interleukin-12 inhibits development of ectopic endometriotic tissues in peritoneal cavity via activation of NK cells in a murine endometriosis model. Cytotechnology 2011, 63:133-141. 10.1007/s10616-010-9321-x, 3080483, 21404062.
134. Ho HN, Chao KH, Chen HF, Wu MY, Yang YS, Lee TY. Peritoneal natural killer cytotoxicity and CD25+ CD3+ lymphocyte subpopulation are decreased in women with stage III-IV endometriosis. Hum Reprod 1995, 10:2671-2675.
135. Becker JC, Dummer R, Hartmann AA, Burg G, Schmidt RE. Shedding of ICAM-1 from human melanoma cell lines induced by IFN-gamma and tumor necrosis factor-alpha. Functional consequences on cell-mediated cytotoxicity. J Immunol 1991, 147:4398-4401.
136. Wu MY, Ho HN. The role of cytokines in endometriosis. Am J Reprod Immunol 2003, 49:285-296. 10.1034/j.1600-0897.2003.01207.x, 12854733.
137. Matalliotakis IM, Vassiliadis S, Goumenou AG, Athanassakis I, Koumantakis GE, Neonaki MA, Koumantakis EE. Soluble ICAM-1 levels in the serum of endometriotic patients appear to be independent of medical treatment. J Reprod Immunol 2001, 51:9-19. 10.1016/S0165-0378(01)00064-X, 11438377.
138. Barrier BF, Sharpe-Timms KL. Expression of soluble adhesion molecules in sera of women with stage III and IV endometriosis. J Soc Gynecol Investig 2002, 9:98-101. 10.1016/S1071-5576(01)00158-7, 11963839.
139. Hsu CC, Yang BC, Wu MH, Huang KE. Enhanced interleukin-4 expression in patients with endometriosis. Fertil Steril 1997, 67:1059-1064. 10.1016/S0015-0282(97)81439-2, 9176444.
140. Hirata T, Osuga Y, Hamasaki K, Yoshino O, Ito M, Hasegawa A, Takemura Y, Hirota Y, Nose E, Morimoto C, Harada M, Koga K, Tajima T, Saito S, Yano T, Taketani Y. Interleukin (IL)-17A stimulates IL-8 secretion, cyclooxygensase-2 expression, and cell proliferation of endometriotic stromal cells. Endocrinology 2008, 149:1260-1267. 10.1210/en.2007-0749, 18079209.
141. Zhang L, Khayat A, Cheng H, Graves DT. The pattern of monocyte recruitment in tumors is modulated by MCP-1 expression and influences the rate of tumor growth. Lab Invest 1997, 76:579-590.
142. Kelly RW, Carr GG, Riley SC. The inhibition of synthesis of a beta-chemokine, monocyte chemotactic protein-1 (MCP-1) by progesterone. Biochem Biophys Res Commun 1997, 239:557-561. 10.1006/bbrc.1997.7502, 9344869.
143. Baka S, Frangou-Plemenou M, Panagiotopoulou E, Makrakis E, Kaltsakas G, Hassiakos D, Kondi-Pafiti A. The expression of human leukocyte antigens class I and II in women with endometriosis or adenomyosis. Gynecol Endocrinol 2011, 27:419-424. 10.3109/09513590.2010.495429, 20569098.
144. Vernet-Tomas Mdel M, Perez-Ares CT, Verdu N, Molinero JL, Fernandez-Figueras MT, Carreras R. The endometria of patients with endometriosis show higher expression of class I human leukocyte antigen than the endometria of healthy women. Fertil Steril 2006, 85:78-83. 10.1016/j.fertnstert.2005.06.057, 16412734.
145. Semino C, Semino A, Pietra G, Mingari MC, Barocci S, Venturini PL, Ragni N, Melioli G. Role of major histocompatibility complex class I expression and natural killer-like T cells in the genetic control of endometriosis. Fertil Steril 1995, 64:909-916.
146. Wang X, Lin Q, Guo S. Study on polymorphism of human leukocyte antigen I in patients with endometriosis. Zhonghua Fu Chan Ke Za Zhi 2001, 36:150-152.
147. Liu Y, Luo L, Zhao H. Immunohistochemical study of HLA-DR antigen in endometrial tissue of patients with endometriosis. J Huazhong Univ Sci Technolog Med Sci 2002, 22:60-61. 10.1007/BF02904791, 12658786.
148. Ota H, Igarashi S. Expression of major histocompatibility complex class II antigen in endometriotic tissue in patients with endometriosis and adenomyosis. Fertil Steril 1993, 60:834-838.
149. Barrier BF, Kendall BS, Ryan CE, Sharpe-Timms KL. HLA-G is expressed by the glandular epithelium of peritoneal endometriosis but not in eutopic endometrium. Hum Reprod 2006, 21:864-869.
150. Maeda N, Izumiya C, Taniguchi K, Matsushima S, Fukaya T. Role of NK cells and HLA-G in endometriosis. Front Biosci 2012, 4:1568-1581.
151. Hornung D, Fujii E, Lim KH, Vigne JL, McMaster MT, Taylor RN. Histocompatibility leukocyte antigen-G is not expressed by endometriosis or endometrial tissue. Fertil Steril 2001, 75:814-817. 10.1016/S0015-0282(00)01791-X, 11287041.
152. Kitawaki J, Xu B, Ishihara H, Fukui M, Hasegawa G, Nakamura N, Mizuno S, Ohta M, Obayashi H, Honjo H. Association of killer cell immunoglobulin-like receptor genotypes with susceptibility to endometriosis. Am J Reprod Immunol 2007, 58:481-486. 10.1111/j.1600-0897.2007.00533.x, 17997746.
153. Ohlsson Teague EM, Van der Hoek KH, Van der Hoek MB, Perry N, Wagaarachchi P, Robertson SA, Print CG, Hull LM. MicroRNA-regulated pathways associated with endometriosis. Mol Endocrinol 2009, 23:265-275. 10.1210/me.2008-0387, 19074548.
154. Hawkins SM, Creighton CJ, Han DY, Zariff A, Anderson ML, Gunaratne PH, Matzuk MM. Functional microRNA involved in endometriosis. Mol Endocrinol 2011, 25:821-832. 10.1210/me.2010-0371, 3082329, 21436257.
155. Pan Q, Luo X, Toloubeydokhti T, Chegini N. The expression profile of micro-RNA in endometrium and endometriosis and the influence of ovarian steroids on their expression. Mol Hum Reprod 2007, 13:797-806. 10.1093/molehr/gam063, 17766684.
156. Petracco R, Grechukhina O, Popkhadze S, Massasa E, Zhou Y, Taylor HS. MicroRNA 135 regulates HOXA10 expression in endometriosis. J Clin Endocrinol Metab 2011, 96:E1925-E1933. 10.1210/jc.2011-1231, 3232619, 21956427.
157. Taylor HS, Bagot C, Kardana A, Olive D, Arici A. HOX gene expression is altered in the endometrium of women with endometriosis. Hum Reprod 1999, 14:1328-1331. 10.1093/humrep/14.5.1328, 10325287.
158. Dai L, Gu L, Di W. MiR-199a attenuates endometrial stromal cell invasiveness through suppression of the IKKbeta/NF-kappaB pathway and reduced interleukin-8 expression. Mol Hum Reprod 2012, 18:136-145. 10.1093/molehr/gar066, 3292395, 21989168.
159. Kaluz S, Kaluzova M, Stanbridge EJ. Regulation of gene expression by hypoxia: integration of the HIF-transduced hypoxic signal at the hypoxia-responsive element. Clin Chim Acta 2008, 395:6-13. 10.1016/j.cca.2008.05.002, 2536516, 18505681.
160. Tamura M, Sebastian S, Yang S, Gurates B, Fang Z, Bulun SE. Interleukin-1beta elevates cyclooxygenase-2 protein level and enzyme activity via increasing its mRNA stability in human endometrial stromal cells: an effect mediated by extracellularly regulated kinases 1 and 2. J Clin Endocrinol Metab 2002, 87:3263-3273.
161. Chakrabarty A, Tranguch S, Daikoku T, Jensen K, Furneaux H, Dey SK. MicroRNA regulation of cyclooxygenase-2 during embryo implantation. Proc Natl Acad Sci U S A 2007, 104:15144-15149. 10.1073/pnas.0705917104, 1986627, 17848513.
162. Meresman GF, Vighi S, Buquet RA, Contreras-Ortiz O, Tesone M, Rumi LS. Apoptosis and expression of Bcl-2 and Bax in eutopic endometrium from women with endometriosis. Fertil Steril 2000, 74:760-766. 10.1016/S0015-0282(00)01522-3, 11020520.
163. Matsuzaki S, Canis M, Pouly JL, Botchorishvili R, Dechelotte PJ, Mage G. Differential expression of genes in eutopic and ectopic endometrium from patients with ovarian endometriosis. Fertil Steril 2006, 86:548-553. 10.1016/j.fertnstert.2006.02.093, 16815388.
164. Fish JE, Santoro MM, Morton SU, Yu S, Yeh RF, Wythe JD, Ivey KN, Bruneau BG, Stainier DY, Srivastava D. miR-126 regulates angiogenic signaling and vascular integrity. Dev Cell 2008, 15:272-284. 10.1016/j.devcel.2008.07.008, 2604134, 18694566.
165. Hull ML, Charnock-Jones DS, Chan CL, Bruner-Tran KL, Osteen KG, Tom BD, Fan TP, Smith SK. Antiangiogenic agents are effective inhibitors of endometriosis. J Clin Endocrinol Metab 2003, 88:2889-2899. 10.1210/jc.2002-021912, 12788903.
166. Schmidt M, Paes K, De Maziere A, Smyczek T, Yang S, Gray A, French D, Kasman I, Klumperman J, Rice DS, Ye W. EGFL7 regulates the collective migration of endothelial cells by restricting their spatial distribution. Development 2007, 134:2913-2923. 10.1242/dev.002576, 17626061.
167. Brosens I, Puttemans P, Campo R, Gordts S, Kinkel K. Diagnosis of endometriosis: pelvic endoscopy and imaging techniques. Best Pract Res Clin Obstet Gynaecol 2004, 18:285-303. 10.1016/j.bpobgyn.2004.03.002, 15157643.
168. Dmowski WP. Pitfalls in clinical, laparoscopic and histologic diagnosis of endometriosis. Acta Obstet Gynecol Scand Suppl 1984, 123:61-66.
169. Elgafor El Sharkwy IA. Combination of non-invasive and semi-invasive tests for diagnosis of minimal to mild endometriosis. Arch Gynecol Obstet 2013, 288:793-797. 10.1007/s00404-013-2822-z, 23545836.
170. Nepomnyashchaya YN, Artemov AV, Roumiantsev SA, Roumyantsev AG, Zhavoronkov A. Non-invasive prenatal diagnostics of aneuploidy using next-generation DNA sequencing technologies, and clinical considerations. Clin Chem Lab Med 2013, 51:1141-1154.
171. Fassbender A, Vodolazkaia A, Saunders P, Lebovic D, Waelkens E, De Moor B, D'Hooghe T. Biomarkers of endometriosis. Fertil Steril 2013, 99:1135-1145. 10.1016/j.fertnstert.2013.01.097, 23414923.
172. May KE, Conduit-Hulbert SA, Villar J, Kirtley S, Kennedy SH, Becker CM. Peripheral biomarkers of endometriosis: a systematic review. Hum Reprod Update 2010, 16:651-674. 10.1093/humupd/dmq009, 2953938, 20462942.
173. Barbieri RL, Niloff JM, Bast RC, Scaetzl E, Kistner RW, Knapp RC. Elevated serum concentrations of CA-125 in patients with advanced endometriosis. Fertil Steril 1986, 45:630-634.
174. Pittaway DE, Douglas JW. Serum CA-125 in women with endometriosis and chronic pelvic pain. Fertil Steril 1989, 51:68-70.
175. Othman Eel D, Hornung D, Salem HT, Khalifa EA, El-Metwally TH, Al-Hendy A. Serum cytokines as biomarkers for nonsurgical prediction of endometriosis. Eur J Obstet Gynecol Reprod Biol 2008, 137:240-246. 10.1016/j.ejogrb.2007.05.001, 17582674.
176. Buzdin AA, Zhavoronkov AA, Korzinkin MB, Venkova LS, Zenin AA, Smirnov PY, Borisov NM. Oncofinder, a new method for the analysis of intracellular signaling pathway activation using transcriptomic data. Front Genet 2014, 5:55. 3971199, 24723936.
177. Zhavoronkov A, Buzdin AA, Garazha AV, Borisov NM, Moskalev AA. Signaling pathway cloud regulation for in silico screening and ranking of the potential geroprotective drugs. Front Genet 2014, 5:49. 3940060, 24624136.
178. Zhavoronkov A, Cantor CR. From personalized medicine to personalized science: uniting science and medicine for patient-driven, goal-oriented research. Rejuvenation Res 2013, 16:414-418. 10.1089/rej.2013.1471, 23889730.
179. Berger SL, Kouzarides T, Shiekhattar R, Shilatifard A. An operational definition of epigenetics. Genes Dev 2009, 23:781-783. 10.1101/gad.1787609, 3959995, 19339683.
180. Holliday R. Epigenetics: an overview. Dev Genet 1994, 15:453-457. 10.1002/dvg.1020150602, 7834903.
181. Esteller M. Cancer epigenomics: DNA methylomes and histone-modification maps. Nat Rev Genet 2007, 8:286-298. 10.1038/nrg2005, 17339880.
182. Nasu K, Kawano Y, Tsukamoto Y, Takano M, Takai N, Li H, Furukawa Y, Abe W, Moriyama M, Narahara H. Aberrant DNA methylation status of endometriosis: epigenetics as the pathogenesis, biomarker and therapeutic target. J Obstet Gynaecol Res 2011, 37:683-695. 10.1111/j.1447-0756.2011.01663.x, 21651673.
183. Guo SW. Epigenetics of endometriosis. Mol Hum Reprod 2009, 15:587-607. 10.1093/molehr/gap064, 19651637.
184. Jaenisch R, Bird A. Epigenetic regulation of gene expression: how the genome integrates intrinsic and environmental signals. Nat Genet 2003, 33(Suppl):245-254.
185. Ehrlich M. Expression of various genes is controlled by DNA methylation during mammalian development. J Cell Biochem 2003, 88:899-910. 10.1002/jcb.10464, 12616529.
186. Hendrich B, Tweedie S. The methyl-CpG binding domain and the evolving role of DNA methylation in animals. Trends Genet 2003, 19:269-277. 10.1016/S0168-9525(03)00080-5, 12711219.
187. Ting AH, Jair KW, Suzuki H, Yen RW, Baylin SB, Schuebel KE. Mammalian DNA methyltransferase 1: inspiration for new directions. Cell Cycle 2004, 3:1024-1026.
188. Robertson KD. DNA methylation and human disease. Nat Rev Genet 2005, 6:597-610.
189. Wu Y, Strawn E, Basir Z, Halverson G, Guo SW. Aberrant expression of deoxyribonucleic acid methyltransferases DNMT1, DNMT3A, and DNMT3B in women with endometriosis. Fertil Steril 2007, 87:24-32. 10.1016/j.fertnstert.2006.05.077, 17081533.
190. Richardson BC. Role of DNA methylation in the regulation of cell function: autoimmunity, aging and cancer. J Nutr 2002, 132:2401S-2405S.
191. Jacob RA, Gretz DM, Taylor PC, James SJ, Pogribny IP, Miller BJ, Henning SM, Swendseid ME. Moderate folate depletion increases plasma homocysteine and decreases lymphocyte DNA methylation in postmenopausal women. J Nutr 1998, 128:1204-1212.
192. Hsieh CJ, Klump B, Holzmann K, Borchard F, Gregor M, Porschen R. Hypermethylation of the p16INK4a promoter in colectomy specimens of patients with long-standing and extensive ulcerative colitis. Cancer Res 1998, 58:3942-3945.
193. Stirzaker C, Song JZ, Davidson B, Clark SJ. Transcriptional gene silencing promotes DNA hypermethylation through a sequential change in chromatin modifications in cancer cells. Cancer Res 2004, 64:3871-3877. 10.1158/0008-5472.CAN-03-3690, 15172996.
194. Izawa M, Taniguchi F, Terakawa N, Harada T. Epigenetic aberration of gene expression in endometriosis. Front Biosci (Elite Ed) 2013, 5:900-910.
195. Wilson VL, Jones PA. DNA methylation decreases in aging but not in immortal cells. Science 1983, 220:1055-1057. 10.1126/science.6844925, 6844925.
196. Issa JP. Age-related epigenetic changes and the immune system. Clin Immunol 2003, 109:103-108. 10.1016/S1521-6616(03)00203-1, 14585281.
197. Bornman DM, Mathew S, Alsruhe J, Herman JG, Gabrielson E. Methylation of the E-cadherin gene in bladder neoplasia and in normal urothelial epithelium from elderly individuals. Am J Pathol 2001, 159:831-835. 10.1016/S0002-9440(10)61758-0, 1850472, 11549575.
198. Starzinski-Powitz A, Gaetje R, Zeitvogel A, Kotzian S, Handrow-Metzmacher H, Herrmann G, Fanning E, Baumann R. Tracing cellular and molecular mechanisms involved in endometriosis. Hum Reprod Update 1998, 4:724-729. 10.1093/humupd/4.5.724, 10027626.
199. Nabeshima T, Hiramatsu M, Furukawa H, Kameyama T. Effects of acute and chronic administrations of phencyclidine on the levels of serotonin and 5-hydroxyindoleacetic acid in discrete brain areas of mouse. Life Sci 1985, 36:939-946. 10.1016/0024-3205(85)90389-3, 2579308.
200. Matsuzaki S, Canis M, Vaurs-Barriere C, Pouly JL, Boespflug-Tanguy O, Penault-Llorca F, Dechelotte P, Dastugue B, Okamura K, Mage G. DNA microarray analysis of gene expression profiles in deep endometriosis using laser capture microdissection. Mol Hum Reprod 2004, 10:719-728. 10.1093/molehr/gah097, 15299092.
201. Xue Q, Lin Z, Cheng YH, Huang CC, Marsh E, Yin P, Milad MP, Confino E, Reierstad S, Innes J, Bulun SE. Promoter methylation regulates estrogen receptor 2 in human endometrium and endometriosis. Biol Reprod 2007, 77:681-687. 10.1095/biolreprod.107.061804, 17625110.
202. Wu Y, Strawn E, Basir Z, Halverson G, Guo SW. Promoter hypermethylation of progesterone receptor isoform B (PR-B) in endometriosis. Epigenetics 2006, 1:106-111. 10.4161/epi.1.2.2766, 17965625.
203. Izawa M, Taniguchi F, Uegaki T, Takai E, Iwabe T, Terakawa N, Harada T. Demethylation of a nonpromoter cytosine-phosphate-guanine island in the aromatase gene may cause the aberrant up-regulation in endometriotic tissues. Fertil Steril 2011, 95:33-39. 10.1016/j.fertnstert.2010.06.024, 20655525.
204. Wu Y, Starzinski-Powitz A, Guo SW. Trichostatin A, a histone deacetylase inhibitor, attenuates invasiveness and reactivates E-cadherin expression in immortalized endometriotic cells. Reprod Sci 2007, 14:374-382. 10.1177/1933719107302913, 17644810.
205. Rice DA, Mouw AR, Bogerd AM, Parker KL. A shared promoter element regulates the expression of three steroidogenic enzymes. Mol Endocrinol 1991, 5:1552-1561. 10.1210/mend-5-10-1552, 1775136.
206. Xue Q, Lin Z, Yin P, Milad MP, Cheng YH, Confino E, Reierstad S, Bulun SE. Transcriptional activation of steroidogenic factor-1 by hypomethylation of the 5′ CpG island in endometriosis. J Clin Endocrinol Metab 2007, 92:3261-3267. 10.1210/jc.2007-0494, 17519303.
207. Zeitoun K, Takayama K, Michael MD, Bulun SE. Stimulation of aromatase P450 promoter (II) activity in endometriosis and its inhibition in endometrium are regulated by competitive binding of steroidogenic factor-1 and chicken ovalbumin upstream promoter transcription factor to the same cis-acting element. Mol Endocrinol 1999, 13:239-253. 10.1210/mend.13.2.0229, 9973254.
208. Utsunomiya H, Cheng YH, Lin Z, Reierstad S, Yin P, Attar E, Xue Q, Imir G, Thung S, Trukhacheva E, Suzuki T, Sasano H, Kim JJ, Yaegashi N, Bulun SE. Upstream stimulatory factor-2 regulates steroidogenic factor-1 expression in endometriosis. Mol Endocrinol 2008, 22:904-914. 10.1210/me.2006-0302, 2276471, 18165439.
209. Gui Y, Zhang J, Yuan L, Lessey BA. Regulation of HOXA-10 and its expression in normal and abnormal endometrium. Mol Hum Reprod 1999, 5:866-873. 10.1093/molehr/5.9.866, 10460226.
210. Wu Y, Halverson G, Basir Z, Strawn E, Yan P, Guo SW. Aberrant methylation at HOXA10 may be responsible for its aberrant expression in the endometrium of patients with endometriosis. Am J Obstet Gynecol 2005, 193:371-380. 10.1016/j.ajog.2005.01.034, 16098858.
211. Streuli I, de Ziegler D, Santulli P, Marcellin L, Borghese B, Batteux F, Chapron C. An update on the pharmacological management of endometriosis. Expert Opin Pharmacother 2013, 14:291-305. 10.1517/14656566.2013.767334, 23356536.
212. Kauppila A, Puolakka J, Ylikorkala O. Prostaglandin biosynthesis inhibitors and endometriosis. Prostaglandins 1979, 18:655-661.
213. Andersson KE. Side-effects of prostaglandin synthetase inhibitors. Acta Obstet Gynecol Scand Suppl 1979, 87:101-104.
214. Abou-Setta AM, Houston B, Al-Inany HG, Farquhar C. Levonorgestrel-releasing intrauterine device (LNG-IUD) for symptomatic endometriosis following surgery. Cochrane Database Syst Rev 2013, 1. CD005072.
215. Lethaby AE1, Cooke I, Rees M. Progesterone or progestogen-releasing intrauterine systems for heavy menstrual bleeding. Cochrane Database Syst Rev 2005, CD002126.
216. Vercellini P, Frontino G, De Giorgi O, Aimi G, Zaina B, Crosignani PG. Comparison of a levonorgestrel-releasing intrauterine device versus expectant management after conservative surgery for symptomatic endometriosis: a pilot study. Fertil Steril 2003, 80:305-309.
217. Petta CA, Ferriani RA, Abrao MS, Hassan D, Rosa ESJC, Podgaec S, Bahamondes L. Randomized clinical trial of a levonorgestrel-releasing intrauterine system and a depot GnRH analogue for the treatment of chronic pelvic pain in women with endometriosis. Hum Reprod 2005, 20:1993-1998. 10.1093/humrep/deh869, 15790607.
218. Bahamondes L, Bahamondes MV. New and emerging contraceptives: a state-of-the-art review. Int J Womens Health 2014, 6:221-234. 3933723, 24570597.
219. Nirgianakis K, Bersinger NA, McKinnon B, Kostov P, Imboden S, Mueller MD. Regression of the inflammatory microenvironment of the peritoneal cavity in women with endometriosis by GnRHa treatment. Eur J Obstet Gynecol Reprod Biol 2013, 170(2):550-554. 10.1016/j.ejogrb.2013.08.010, 23993133.
220. Taniguchi F, Higaki H, Azuma Y, Deura I, Iwabe T, Harada T, Terakawa N. Gonadotropin-releasing hormone analogues reduce the proliferation of endometrial stromal cells but not endometriotic cells. Gynecol Obstet Invest 2013, 75:9-15. 10.1159/000343748, 23147672.
221. Rodriguez-Purata J, Coroleu B, Tur R, Carrasco B, Rodriguez I, Barri PN. Endometriosis and IVF: are agonists really better? Analysis of 1180 cycles with the propensity score matching. Gynecol Endocrinol 2013, 29:859-862. 10.3109/09513590.2013.808327, 23875964.
222. Nyholt DR, Low SK, Anderson CA, Painter JN, Uno S, Morris AP, MacGregor S, Gordon SD, Henders AK, Martin NG, Attia J, Holliday EG, McEvoy M, Scott RJ, Kennedy SH, Treloar SA, Missmer SA, Adachi S, Tanaka K, Nakamura Y, Zondervan KT, Zembutsu H, Montgomery GW. Genome-wide association meta-analysis identifies new endometriosis risk loci. Nat Genet 2012, 44:1355-1359. 10.1038/ng.2445, 3527416, 23104006.
223. Painter JN, Anderson CA, Nyholt DR, Macgregor S, Lin J, Lee SH, Lambert A, Zhao ZZ, Roseman F, Guo Q, Gordon SD, Wallace L, Henders AK, Visscher PM, Kraft P, Martin NG, Morris AP, Treloar SA, Kennedy SH, Missmer SA, Montgomery GW, Zondervan KT. Genome-wide association study identifies a locus at 7p15.2 associated with endometriosis. Nat Genet 2011, 43:51-54. 10.1038/ng.731, 3019124, 21151130.
224. Adachi S, Tajima A, Quan J, Haino K, Yoshihara K, Masuzaki H, Katabuchi H, Ikuma K, Suginami H, Nishida N, Kuwano R, Okazaki Y, Kawamura Y, Sasaki T, Tokunaga K, Inoue I, Tanaka K. Meta-analysis of genome-wide association scans for genetic susceptibility to endometriosis in Japanese population. J Hum Genet 2010, 55:816-821. 10.1038/jhg.2010.118, 20844546.
225. Uno S, Zembutsu H, Hirasawa A, Takahashi A, Kubo M, Akahane T, Aoki D, Kamatani N, Hirata K, Nakamura Y. A genome-wide association study identifies genetic variants in the CDKN2BAS locus associated with endometriosis in Japanese. Nat Genet 2010, 42:707-710. 10.1038/ng.612, 20601957.
226. Calo V, Migliavacca M, Bazan V, Macaluso M, Buscemi M, Gebbia N, Russo A. STAT proteins: from normal control of cellular events to tumorigenesis. J Cell Physiol 2003, 197:157-168. 10.1002/jcp.10364, 14502555.
227. Liongue C, Ward AC. Evolution of the JAK-STAT pathway. JAKSTAT 2013, 2:e22756. 3670263, 24058787.
228. Timofeeva OA, Tarasova NI. Alternative ways of modulating JAK-STAT pathway: Looking beyond phosphorylation. JAKSTAT 2012, 1:274-284. 3670285, 24058784.
229. Turkson J, Jove R. STAT proteins: novel molecular targets for cancer drug discovery. Oncogene 2000, 19:6613-6626. 10.1038/sj.onc.1204086, 11426647.
230. Bowman T, Garcia R, Turkson J, Jove R. STATs in oncogenesis. Oncogene 2000, 19:2474-2488. 10.1038/sj.onc.1203527, 10851046.
231. Buettner R, Mora LB, Jove R. Activated STAT signaling in human tumors provides novel molecular targets for therapeutic intervention. Clin Cancer Res 2002, 8:945-954.
232. Bromberg JF, Wrzeszczynska MH, Devgan G, Zhao Y, Pestell RG, Albanese C, Darnell JE. Stat3 as an oncogene. Cell 1999, 98:295-303. 10.1016/S0092-8674(00)81959-5, 10458605.
233. Fukada T, Ohtani T, Yoshida Y, Shirogane T, Nishida K, Nakajima K, Hibi M, Hirano T. STAT3 orchestrates contradictory signals in cytokine-induced G1 to S cell-cycle transition. EMBO J 1998, 17:6670-6677. 10.1093/emboj/17.22.6670, 1171012, 9822610.
234. Niu G, Wright KL, Huang M, Song L, Haura E, Turkson J, Zhang S, Wang T, Sinibaldi D, Coppola D, Heller R, Ellis LM, Karras J, Bromberg J, Pardoll D, Jove R, Yu H. Constitutive Stat3 activity up-regulates VEGF expression and tumor angiogenesis. Oncogene 2002, 21:2000-2008. 10.1038/sj.onc.1205260, 11960372.
235. Mori S, Matsuzaki K, Yoshida K, Furukawa F, Tahashi Y, Yamagata H, Sekimoto G, Seki T, Matsui H, Nishizawa M, Fujisawa J, Okazaki K. TGF-beta and HGF transmit the signals through JNK-dependent Smad2/3 phosphorylation at the linker regions. Oncogene 2004, 23:7416-7429. 10.1038/sj.onc.1207981, 15326485.
236. Massague J. TGF-beta signal transduction. Annu Rev Biochem 1998, 67:753-791. 10.1146/annurev.biochem.67.1.753, 9759503.
237. Massague J, Wotton D. Transcriptional control by the TGF-beta/Smad signaling system. EMBO J 2000, 19:1745-1754. 10.1093/emboj/19.8.1745, 302010, 10775259.
238. Grady WM. Transforming growth factor-beta, Smads, and cancer. Clin Cancer Res 2005, 11:3151-3154. 10.1158/1078-0432.CCR-05-0414, 15867206.
239. Meng XM, Chung AC, Lan HY. Role of the TGF-beta/BMP-7/Smad pathways in renal diseases. Clin Sci 2013, 124:243-254. 10.1042/CS20120252, 23126427.
240. Malhotra N, Kang J. SMAD regulatory networks construct a balanced immune system. Immunology 2013, 139:1-10. 10.1111/imm.12076, 3634534, 23347175.
241. Chappell WH, Steelman LS, Long JM, Kempf RC, Abrams SL, Franklin RA, Basecke J, Stivala F, Donia M, Fagone P, Malaponte G, Mazzarino MC, Nicoletti F, Libra M, Maksimovic-Ivanic D, Mijatovic S, Montalto G, Cervello M, Laidler P, Milella M, Tafuri A, Bonati A, Evangelisti C, Cocco L, Martelli AM, McCubrey JA. Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR inhibitors: rationale and importance to inhibiting these pathways in human health. Oncotarget 2011, 2:135-164. 3260807, 21411864.
242. Maurer G, Tarkowski B, Baccarini M. Raf kinases in cancer-roles and therapeutic opportunities. Oncogene 2011, 30:3477-3488. 10.1038/onc.2011.160, 21577205.
243. Roskoski R. ERK1/2 MAP kinases: structure, function, and regulation. Pharmacol Res 2012, 66:105-143. 10.1016/j.phrs.2012.04.005, 22569528.
244. Ivanenkov YA, Balakin KV, Lavrovsky Y. Small molecule inhibitors of NF-kB and JAK/STAT signal transduction pathways as promising anti-inflammatory therapeutics. Mini Rev Med Chem 2011, 11:55-78. 10.2174/138955711793564079, 21034406.
245. Nagaraj NS, Datta PK. Targeting the transforming growth factor-beta signaling pathway in human cancer. Expert Opin Investig Drugs 2010, 19:77-91. 10.1517/13543780903382609, 2796203, 20001556.